Large cell neuroendocrine carcinoma
Clinical trials for Large cell neuroendocrine carcinoma explained in plain language.
Never miss a new study
Get alerted when new Large cell neuroendocrine carcinoma trials appear
Sign up with your email to follow new studies for Large cell neuroendocrine carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare cancers: Triple-Drug attack shows promise
Disease control Recruiting nowThis phase II trial is testing whether a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—can shrink or slow the growth of rare genitourinary cancers that have spread. About 314 adults with these uncommon tumors will receive the drugs. The goal is to see if the …
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New radioactive 'Smart Bomb' targets Hard-to-Treat lung cancer
Disease control Recruiting nowThis study tests a new drug that delivers radiation directly to cancer cells carrying a protein called DLL3, found in small cell lung cancer and other solid tumors. The trial enrolls 138 adults whose cancer has progressed after at least two prior treatments. The goal is to check …
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA
Phase 1/2 • Sponsor: Molecular Partners AG • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for Hard-to-Treat cancers: first human trial begins
Disease control Recruiting nowThis early-stage study tests a new drug called FZ-AD005 in people with advanced solid tumors, especially small cell lung cancer and large cell neuroendocrine carcinoma. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. About 162 partic…
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA
Phase 1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New study maps cancer treatment journeys across latin america
Knowledge-focused Recruiting nowThis study looks back at medical records of 200 adults in Latin America with a rare and aggressive cancer called neuroendocrine carcinoma. Researchers want to understand how patients are diagnosed, what treatments they receive, and how their disease progresses over time. The goal…
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA
Sponsor: Latin American Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC